Enzo Biochem (ENZ) Reports In-Line Q1 Loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SPY
9. SWKS
10. FISV

Go back to Enzo Biochem (ENZ) Reports In-Line Q1 Loss

Enzo Biochem Reports Strong First Quarter

December 7, 2015 4:15 PM EST

Execution on Corporate Strategy seen in Companys Results

NEW YORK--(BUSINESS WIRE)-- Enzo Biochem Inc. (NYSE: ENZ) today reported another period of strong results for the first fiscal quarter ended October 31, 2015.

First Quarter Highlights

Strong financial performance at Enzo Clinical Labs and new legal settlements contributes to year-over year revenues and net income gains. Total Revenue was $25.2 million with Clinical Lab Revenue of $17.1 million up 8% over prior year. Gross margins at the Lab climbed to 40%, an increase of 400 basis... More